Sign in
Taking people in United StatesNo phase

Testing in vitro maturation of eggs in women with fertility concerns

Tests in vitro maturation of human eggs in women with PCOS or infertility.

Key facts

Who runs it
Colorado Center for Reproductive Medicine
Where
Lone Tree, United StatesSee the site
Trial code
Registry title
In Vitro Maturation of Human Eggs
Status
Recruiting
People taking part
50 people, planned
Started
3 Feb 2023
Expected to end
30 Aug 2030
Type of study
Interventional
Treatments tested
  • IVM
Record updated
9 October 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with fertility problems who have polycystic ovaries (PCOS) or a good egg supply, to test egg maturation in the lab (IVM).

Age
Up to 38 years.
Sex
Women only.
Disease stage
Infertility with PCOS or polycystic ovaries, or with good ovarian reserve. Antral follicle count greater than 24, AMH greater than 3.5 ng/ml.
Earlier treatment
No more than 2 failed IVF cycles.
Biomarker or test result
AMH greater than 3.5 ng/ml; antral follicle count (AFC) greater than 24.

Main reasons for not taking part

  • More than 2 failed IVF cycles
  • Body Mass Index of 35 or more
  • Not willing to have embryos biopsied for PGT
  • Not planning an embryo transfer within 4 months after the IVM cycle
  • Sperm or partner age outside the limits (paternal or donor age under 45, sperm morphology >1%, motility >20%, sperm count >10 million per ml)

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Infertile women diagnosed with PCOS or polycystic ovaries, or infertile women with good ovarian reserve
  • Antral follicle count (AFC) greater than 24
  • AMH greater than 3.5 ng/ml
  • Body Mass Index less than 35
  • Accept to have embryos biopsied for PGT
  • Intend to perform embryo transfer within 4 months after completing the IVM cycle
  • Paternal (or donor) age \<45, ejaculated sperm collection only (partner frozen and donor sperm acceptable), sperm morphology (strict criteria) \>1%, motility \> 20% and sperm count \> 10 million per ml (so samples can be prepared through standard procedure)

Who cannot take part

  • More than 2 failed IVF cycles

Where in United States

  • Colorado Center for Reproductive MedicineLone Tree, United StatesContact: Rachel Study CoordinatorTaking people

About the trial

What the trial wants to find out

CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will receive a free cycle of IVM treatment at CCRM Fertility and including a new patient consultation, fertility testing, preimplantation genetic testing for aneuploidies (PGT-A), anesthesia and some medication

The group in the trial

  • Biphasic IVM TreatmentTreatment being tested

    Biphasic IVM of oocytes

    Treatment: IVM

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
In Vitro Maturation of Human Eggs
Plain-language title
Testing in vitro maturation of eggs in women with fertility concernsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
9 October 2024